Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis

BACKGROUND: Berberine is used to treat diabetes and dyslipidemia. However, the effect of berberine on specific diabetes treatment targets is unknown. In the current study, we investigated the effect of berberine on the random plasma glucose, glycated hemoglobin (HbA1C), AST, ALT, BUN and CREA levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yang Sheng, Chen, Yi-Tao, Bao, Yu-Ting, Li, Zhe-Ming, Zhou, Xiao-Jie, He, Jia-Na, Dai, Shi-Jie, Li, Chang yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112949/
https://www.ncbi.nlm.nih.gov/pubmed/27846294
http://dx.doi.org/10.1371/journal.pone.0166378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112949/
https://www.ncbi.nlm.nih.gov/pubmed/27846294
http://dx.doi.org/10.1371/journal.pone.0166378

Ejemplares similares